Antiemetic drug not tied to adverse pregnancy outcomes

02/27/2013 | Family Practice News

The prenatal use of ondansetron, an antiemetic for treating nausea and vomiting during pregnancy, was not linked to increased odds of still birth, preterm delivery, birth defects, or low birth weight or small-for-gestational-age babies, Danish researchers found. The study was published in the New England Journal of Medicine.

View Full Article in:

Family Practice News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID